Ellington Management Group’s Novartis NVS Stock Holding History

Ellington Management Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,300	Closed	-$272K	–	304
2020 Q1	$272K	Buy	3,300 +500	+18%	+$44.6K	0.06%	351
2019 Q4	$265K	Sell	2,800 -1,700	-38%	-$153K	0.06%	349
2019 Q3	$391K	Buy	+4,500	New	+$404K	0.07%	290
2018 Q4	–	Sell	-10,267	Closed	-$793K	–	542
2018 Q3	$793K	Buy	+10,267	New	+$759K	0.21%	135
2016 Q4	–	Sell	-9,932	Closed	-$703K	–	729
2016 Q3	$703K	Buy	+9,932	New	+$724K	0.19%	164

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ellington Management Group's NVS Position: Q2 2020 in Review

Ellington Management Group sold out of Novartis (NVS) in Q2 2020, closing a stake of 3,300 shares — an estimated $272K sold.

Ellington Management Group first reported a position in NVS in Q3 2016 and held it in 5 quarters. The position peaked at $793K in Q3 2018. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Ellington Management Group reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 3,300 Novartis shares in Q2 2020, an estimated $272K.
Ellington Management Group first reported a position in Novartis in Q3 2016 and held it in 5 quarters.
Ellington Management Group's Novartis position peaked at $793K in Q3 2018.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.